Harmony Biosciences Holdings, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Harmony Biosciences Holdings, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2019 to Q3 2024.
  • Harmony Biosciences Holdings, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $46.1M, a 19.8% increase year-over-year.
  • Harmony Biosciences Holdings, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was $123M, a 18.7% decline year-over-year.
  • Harmony Biosciences Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was $129M, a 29% decline from 2022.
  • Harmony Biosciences Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $181M, a 425% increase from 2021.
  • Harmony Biosciences Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $34.6M.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $123M $46.1M +$7.63M +19.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-29
Q2 2024 $115M $11.6M -$22.7M -66.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $138M $38.3M +$8.85M +30% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-30
Q4 2023 $129M $26.6M -$21.9M -45.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 $151M $38.5M -$49.5M -56.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-29
Q2 2023 $200M $34.3M +$10.8M +45.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $189M $29.5M +$8M +37.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-30
Q4 2022 $181M $48.5M +$25.8M +114% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 $156M $87.9M +$97.6M Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-31
Q2 2022 $58.1M $23.5M +$9.41M +66.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 $48.7M $21.5M +$14.1M +191% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 $34.6M $22.7M +$22.9M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-22
Q3 2021 $11.7M -$9.62M -$11.5M -604% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $23.2M $14.1M +$14.1M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $9.06M $7.39M +$46M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 -$36.9M -$206K Oct 1, 2020 Dec 31, 2020 10-K 2023-02-21
Q3 2020 $1.91M +$33.8M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$27K* Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 -$38.6M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q3 2019 -$31.9M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.